1. Home
  2. PEPG vs LND Comparison

PEPG vs LND Comparison

Compare PEPG & LND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEPG
  • LND
  • Stock Information
  • Founded
  • PEPG 2018
  • LND 2005
  • Country
  • PEPG United States
  • LND Brazil
  • Employees
  • PEPG N/A
  • LND N/A
  • Industry
  • PEPG Biotechnology: Pharmaceutical Preparations
  • LND Farming/Seeds/Milling
  • Sector
  • PEPG Health Care
  • LND Consumer Staples
  • Exchange
  • PEPG Nasdaq
  • LND Nasdaq
  • Market Cap
  • PEPG 317.6M
  • LND 376.5M
  • IPO Year
  • PEPG 2022
  • LND 2006
  • Fundamental
  • Price
  • PEPG $4.62
  • LND $3.66
  • Analyst Decision
  • PEPG Strong Buy
  • LND
  • Analyst Count
  • PEPG 6
  • LND 0
  • Target Price
  • PEPG $8.17
  • LND N/A
  • AVG Volume (30 Days)
  • PEPG 9.6M
  • LND 34.9K
  • Earning Date
  • PEPG 11-06-2025
  • LND 11-05-2025
  • Dividend Yield
  • PEPG N/A
  • LND 6.74%
  • EPS Growth
  • PEPG N/A
  • LND N/A
  • EPS
  • PEPG N/A
  • LND 0.25
  • Revenue
  • PEPG N/A
  • LND $194,084,753.00
  • Revenue This Year
  • PEPG N/A
  • LND $40.80
  • Revenue Next Year
  • PEPG N/A
  • LND $5.24
  • P/E Ratio
  • PEPG N/A
  • LND $14.52
  • Revenue Growth
  • PEPG N/A
  • LND 3.73
  • 52 Week Low
  • PEPG $0.88
  • LND $3.49
  • 52 Week High
  • PEPG $9.37
  • LND $4.58
  • Technical
  • Relative Strength Index (RSI)
  • PEPG 63.02
  • LND 36.43
  • Support Level
  • PEPG $4.70
  • LND $3.68
  • Resistance Level
  • PEPG $5.20
  • LND $3.80
  • Average True Range (ATR)
  • PEPG 0.56
  • LND 0.09
  • MACD
  • PEPG 0.00
  • LND -0.02
  • Stochastic Oscillator
  • PEPG 59.00
  • LND 0.00

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.

About LND Brasilagro Brazilian Agric Real Estate Co Sponsored ADR (Brazil)

Brasilagro - Cia Bras de Prop Agricolas is a Brazil-based company, engaged in the acquisition, development, operation, and sale of rural properties suitable for agricultural activities. The business activity of the firm is operated through Real estate, Grains, Sugarcane, Cattle rising, Cotton, and Other segments. The Grains segment is involved in the production and sale of soybean and corn. The Sugarcane segment includes the sale of raw product. The Real Estate segment presents the P&L from operations carried out in the company's subsidiaries. The Cattle Raising segment consists of producing and selling beef calves after weaning, which characterizes the activity as breeding and the Other segment engages in other corporate activities. The majority of revenue is earned from Grain Segment.

Share on Social Networks: